Hello,

Wondering what others are doing regarding the Lidocaine w/Epi and bupivacaine w/Epi shortage. Thank you.

Do you use "barn" doors (top and bottom halves of the door open separately) at your institution, particularly in behavioral health (BH) areas? Any pros/cons or regulatory issues to share? I would also be interested in hearing about BH room designs for prepping and administering meds where patients come to the med room (versus the meds being taken to the patients).

Current practice in our OR is anesthesia fills their machines with the gas and then the bottle is returned to the ADC to ensure these are locked up. The problem, however, is the bottles being returned are partial (open) bottles. Thinking about maintaining integrity, would there be any concerns with these partial bottles remaining in the ADCs? Outside of keeping these locked up, the only other option would be to top off the reservoir and then waste the remaining amount. We want to ensure we can speak to the integrity if anything is mentioned during a survey.

We are working to build some type of prescribing alert for transdermal fentanyl to deter the prescriber from ordering in opioid-naïve patients. Would any of you be willing to share what alert (if any) you have built at your institution and what EMR you use?

Hi!

We have been having some issues with "missing medications" related to standard administration times. To help us solve this can you answer the following.
Ideally, only pediatric dispensing please answer as we know those doses all have to be drawn up individually rather than a standard stock dose that can be stored in Pyxis...(Thanks)

I hope this makes sense to you...

Has anyone noticed a recent spate of low vancomycin troughs despite adequate dosing? We are seeing a larger number of low troughs are investigating possible reasons. Just reaching out to see if anyone else is seeing something similar.

Randi

Hi,

Curious what data and metrics other Med Safety Officers report out at their Medication Safety Meetings and the frequency of reporting this data. Do you have a set of canned reports that you are willing to share regarding what is specifically looked at?

I know there are the obvious (by drug category, by severity, etc), but wonder if we are missing anything that you find useful and potentially actionable.

Appreciate any insight.

For institutions that use a digital refractometer as part of your Controlled-Substance Monitoring / Diversion Prevention plan, is there a reference that lists the refraction indexes of all injectable controlled substances?

Thank you!

Thrombolysis patients are often treated with heparin and/or tPA through the sheath post procedure. If your organization does thrombolysis, does nursing transduce the sheath post procedure? Is this also true when continuous infusions of heparin/tPA are infusing in the line? Do you have a policy you can share? Any literature to support your decision? I have not been able to find any literature for this specific patient population. Thanks.